Abstract
COVID-19 should be considered as a new triggering factor for autoimmune disorders like DM-lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID-19.
Author supplied keywords
Cite
CITATION STYLE
APA
Shahidi Dadras, M., Rakhshan, A., Ahmadzadeh, A., Hosseini, S. A., Diab, R., Safari Giv, T., & Abdollahimajd, F. (2021). Dermatomyositis-lupus overlap syndrome complicated with cardiomyopathy after SARS-CoV-2 infection: A new potential trigger for musculoskeletal autoimmune disease development. Clinical Case Reports, 9(10). https://doi.org/10.1002/ccr3.4931
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free